{
    "2019-06-18": [
        [
            {
                "time": "2023-11-15",
                "original_text": "Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Victoza",
                        "FDA",
                        "Pediatric"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-11-15",
                "original_text": "The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale",
                "features": {
                    "keywords": [
                        "PhaseBio",
                        "Eiger",
                        "Breakthrough Therapy",
                        "Biohaven",
                        "Stock Sale"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-11-15",
                "original_text": "Shares of cancer-therapy companies skyrocket after Pfizer acquisition news",
                "features": {
                    "keywords": [
                        "cancer-therapy",
                        "Pfizer",
                        "acquisition"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}